
Press Room
ISTH Congress Press Room
The ISTH 2026 Congress took place from July 11-15, 2026 in Paris, France. The ISTH 2026 Congress welcomed the highest in-person attendance at an ISTH Congress in more than a decade, as well as a scientific program that featured more than 3,100 abstract submissions. See below for highlights from the Congress press coverage and more information about the press program.
Press Coverage Highlights
See below for press coverage highlights from the ISTH 2026 Congress. If you have an article to share, please email it to media@isth.org.
-
The Limbic: Aspirin matches rivaroxaban for post-arthroplasty VTE
-
Hemophilia News Today: Experimental treatment maintains low bleed rates in hemophilia A
-
MedPage Today: Aspirin Alone Gets the Job Done for Clot Prevention After Joint Surgery
-
Cleveland Clinic: New Global Report Outlines Strategies to Improve Hematologic Care for Women
-
Journal da Unicamp (Brazil): Unicamp Center initiates groundbreaking epidemiological research on thrombosis in Brazil
-
The Limbic: Lancet, ISTH target inequities in women’s haematology
-
Columbia University School of Public Health: Lancet Landmark Commission Reports on Global Female Health: Takes Lifespan Approach to Menstruation
-
HCP Live (Video): AXIOMATIC-TKR: Milvexian Decouples Thrombosis, Hemostasis in DVT
-
Docwire News: Patient Quality of Life versus Quantitative Health Measures in Chronic ITP
-
Docwire News: A New Strategy to Control Bleeding Disorders Clears a Key Safety Hurdle
-
Docwire News: Could Efgartigimod Expand Treatment Possibilities for Patients With Refractory ITP?
-
Docwire News: BASIS KIDS Phase 3 Trial Releases Encouraging Interim Data on Marstacimab for Hemophilia A, B
-
First Word Pharma: Novel point-of-care assay delivers rapid TTP diagnosis
-
First Word Pharma: Once-weekly marstacimab reduces bleeding rates in children with haemophilia
-
First Word Pharma: Aspirin alone matches rivaroxaban strategy after hip, knee replacement surgery
-
OncoDaily: Sushmita Sen։ Meaningful Partnerships Drive Change That Matters
-
Inside Precision Medicine: Simple Test Can Rule Out Pulmonary Embolism in Cancer Patients
-
Bioengineer: YEARS Algorithm Enhances Pulmonary Embolism Diagnosis in Cancer Patients
-
Medical Xpress: Aspirin matches costlier blood thinners after hip and knee replacement surgery, major trial finds
-
WebMD: FDA Approves Wilate to Help Prevent Bleeding in Young Children With von Willebrand Disease
-
BioWorld: Takeda's mezagitamab adds quality-of-life gains to ITP responses
ISTH press contact:
Barbara Krolak
ISTH Marketing Manager
ISTH media policy:
Any media outlet or press representative wishing to attend an ISTH Event and/or to obtain official press releases from the ISTH Press Office must commit to respecting any and all embargoes set by the ISTH.
Read the ISTH Embargo Policy here. Press representatives who receive embargoed material from the ISTH understand that it is for their individual use and will not distribute the embargoed information to anyone else prior to the embargo release.
Embargoed materials include, but are not limited to, original journal articles, abstracts from scientific meetings, written news releases, audio news releases, video news releases, slides and any other materials associated with the scientific information being presented or published.
Photo and video rules:
-
Presenters are the sole proprietors of the content they disclose at ISTH events (data, photographs, slides, etc.) It is the responsibility of presenters or speakers to notify the audience of any restrictions on photographing the content they are presenting. The announcement must be made at the beginning of each presentation.
-
Video recording, audio recording or image caption during a scientific presentation, a session or in the virtual exhibition is strictly prohibited.
-
Any public dissemination of photos or videos taken at an ISTH must include the event.
-
The official ISTH trademark and/or logo may not be added without ISTH prior written approval.
-
Any video transmission or webcast from an ISTH event must adhere to the Embargo Policy.
-
Video filming in the congress center is not allowed without prior written approval from the ISTH. The ISTH reserves the right to stop any unauthorized photography or video filming and to request deletion of unapproved materials. Violations may result in removal from the congress center.
The ISTH is committed to fostering accurate and responsible reporting on the Congress's scientific advancements. Thank you for your cooperation in meeting these requirements.
CME policy:
Providing continuing medical education (CME) credits in association with press coverage of the ISTH 2026 Congress is strictly prohibited. Companies offering continuing medical education credits in association with the ISTH Congress do not qualify for press registration, and access will be revoked if this activity is revealed.
Organizations that plan to offer CME-related content must obtain a separate agreement with the ISTH. Contact meetings@isth.org for more details.
Branding:
ISTH and/or affiliated trademarks including the ISTH 2026 logo are the property of the ISTH. They cannot be used, reproduced or associated with any article or press release without the prior written permission of the ISTH.
Signing of the ISTH Media and Embargo Policy is a prerequisite for Press Registration (whether online or on-site). The ISTH does not make its press database or registration lists available to third parties.
ISTH 2026 Congress News:
July 13, 2026: The Lancet Haematology publishes landmark Commission on Global Female Health at ISTH 2026 Congress
July 8, 2026: ISTH launches women's health hub, expanding access to resources for bleeding & clotting disorders
July 2, 2026: Simultaneous publications at ISTH 2026
July 1, 2026: ISTH 2026 draws largest in-person audience in over a decade as late-breakthrough abstracts unveiled
June 29, 2026: Now available: View the ISTH 2026 full abstracts
June 1, 2026: The road to Paris is coming into view: What you need to know ahead of ISTH 2026
December 1, 2025: ISTH opens call for abstract submissions for 2026 Congress in Paris
December 4, 2024: International Society on Thrombosis and Haemostasis announces Paris as host city for 2026 Congress
Industry News:
Sobi to showcase new data across haemophilia portfolio at ISTH 2026
Star Therapeutics to Present Complete Data from Phase 1/2 Multidose Study of VGA039 in Von Willebrand Disease at ISTH 2026 Congress
Star Therapeutics to present VGA039 data at ISTH congress